New CME Activity: Part 2 of the HDL-focused, iNewsetter Series
The NLA is pleased to announce the launch of Issue 2: HDL and Atherogenesis, the second part of the 3-part iNewsletter Series, Managing Residual CVD Risk: The Role of HDL Cholesterol.
The goal of this educational activity is to expand the ability of health care professionals to successfully manage and treat residual risk in cardiovascular disease (CVD) due to abnormally low or dysfunctional HDL. This interactive-newsletter will evaluate HDL-C as a tool to assess an individual's cardiovascular risk and examine the various atheroprotective functions of HDL and their role in determining CHD risk.
